Trial Shows Promise in Fight Against Rare, Aggressive Breast Cancer - Diverse Health

Higher Education News and Jobs

Trial Shows Promise in Fight Against Rare, Aggressive Breast Cancer

Email
   
        


by Maria Cohut

A recent clinical trial could change the face of therapy for a very aggressive and stubborn form of breast cancer: triple-negative. A combination of chemotherapy and immunotherapy boosts survival rates, the scientists found.

Triple-negative breast cancer is so called since its cells lack receptors for two hormones (estrogen and progesterone) and one protein (HER2).

Read More

Comments

Print Friendly